Mediso

The company began as a provider of servicing for the products of the state-owned Gamma Művek (Gamma Works) instrument maker, and started producing its own equipment in 1994.^[6] In 1998 it acquired the nuclear medicine assets of Gamma Works.^[7][8]

Mediso is unique amongst clinical diagnostic imaging manufacturers in offering a modular three-modality combined SPECT-PET-CT imaging system.^[9] This system was selected by the UK's metrology institute, the NPL, as the basis for its work in quantification of nuclear medicine.^[10]

The company is active in preclinical imaging, marketing a range of hybrid imaging systems in many combinations including PET-MR and SPECT-MR.^[11][12] Preclinical products were initially developed in collaboration with Bioscan, an American company, with Mediso as OEM, however following a dispute over payment and contract terms Bioscan was dissolved in 2013 and ongoing support for the products developed under the partnership fell to Mediso.^[13][14][15]